Methoxy VO-salen stimulates pancreatic β cell survival by upregulation of eNOS and downregulation of apoptosis in STZ-induced diabetic rats

Biological Trace Element Research

Volumn 144, Issue 1-3, 2011, Pages 1095-1111

  Roy, Souvik ^a   Mondru, Anil Kumar ^b   Dontamalla, Sudheer Kumar ^b   Vaddepalli, Ram Prasad ^b   Sannigrahi, Santanu ^a   Veerareddy, Prabhakar Reddy ^b  

^a NSHM Business School   (India)

^b ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Apoptosis; Endothelial nitric oxide synthase; MetVO salen; Rat pancreas; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHOXY VANADIUM OXIDE SALEN COMPLEX; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STIMULATION; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; CELL SURVIVAL; COORDINATION COMPLEXES; DIABETES MELLITUS, EXPERIMENTAL; DIET; DOWN-REGULATION; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INSULIN-SECRETING CELLS; LIPID PEROXIDATION; LIPIDS; MALE; NITRIC OXIDE SYNTHASE TYPE III; PANCREAS; RATS; RATS, WISTAR; UP-REGULATION;

RATTUS;

EID: 84155167815     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-011-9139-1     Document Type: Article

References (57)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes; estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
2. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820 (Pubitemid 34000785)
3. Pyorala K, Laakso M, Unsitupa M (1987) Diabetes and atherosclerosis an epidemiologic view. Diabetes Metab 3:463-524
4. Moskovitz J, Yim MB, Chock PB (2002) Free radicals and disease. Arch Biochem Biophys 397:354-359 (Pubitemid 34852303)
5. Pryor WA (1991) The antioxidant, nutrients and disease prevention: what do we know and what do we need to find out. Am J Clin Nutr 53:391-393
6. Lai LS, Chou ST, Chao WW (2001) Studies on the antioxidative activities of Hsian-tsao (Mesona procumbens Hemsl) Leaf Gum. J Agric Food Chem 49:963-968
7. Riley DP (1999) Functional mimics of superoxide dismutase enzymes as therapeutic agents. Chem Rev 99:2573-2588
8. Autzen S, Korth HG, Boese R, Groot H,Sustmann R (2003) Studies of pyridinyl containing 14 membered macrocyclic copper (II) complexes. Eur J Inorg Chem 1401-1410
9. Bishayee A, Chatterjee M (1995) Time course effects of vanadium supplementation on cytosolic reduced glutathione S-transferase activity. Biol Trace Element Res 48:275-285
10. Combest WL, Jhonson R (1993) Detergent induced distinction between fluoride and vanadate stimulated adenylate cyclases and their responses to guanine nucleotides. Arch Biochem Biophys 225:916-927
11. Shi X, Dalat NS (1990) Glutathione reductase functions as vanadate(V) reductase. Arch Biochem Biophys 278:228-290
12. Gai PL, Kourtakis K (1995) Solid state defect mechanism in vanadyl pyrophosphate catalyst implications for selective oxidation. Science 267:661-663
13. Thompson KH, Orvig C (2004) Vanadium compounds in the treatment of diabetes. Met Ions Biol Syst 41:221-225
14. Sakurai H (2005) Therapeutic potential of vanadium in treating diabetes mellitus. Clin Calcium 15:49-57
15. Sakurai H, Kojima Y, Yoshikawa Y, Kawabe K, Yasui H (2002) Anti diabetic vanadium (IV) and zinc (II) complexes. Coor Chem Rev 226:187-198
16. Goc A (2006) Biological activity of vanadium compounds. Cent Eur Biol 1:314-332 (Pubitemid 44334815)
17. 4- induced oxidative stress in rats. Food Chem Toxicol 47:716-721
18. Szkudelski T (2001) The mechanism of alloxan and streptozotocin in action in beta cells of rat pancreas. Physiol Res 50:536-546
19. Mythili MD, Vyas R, Akila G, Gunasekaran S (2004) Effect of streptozotocin on the ultra structure of rat pancreatic islets. Microsc Res Tech 63:274-281 (Pubitemid 38702356)
20. Bredt DS, Snyder SH (1992) Biological roles of nitric oxide. Sci Am 68-77
21. Forstermann U, Boissel JP, Kleinet H (1998) Expressional control of the constitutive isoforms of nitric oxide synthase (NOS I and NOS III). Fed Am Soc Exp Biol 12:773-790 (Pubitemid 28294668)
22. Leighton F, Miranda-Rottmann S, Urquiaga I (2006) A central role of eNOS in the protective effect of wine against metabolic syndrome. Cell Biochem Funct 24:291-298 (Pubitemid 44065231)
23. Duplain H, Burcelin R, Sartori C (2001) Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104:342-345 (Pubitemid 32666958)
24. Balon TW, Nadler JL (1997) Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 82:359-363 (Pubitemid 27052084)
25. Bergandi L, Silvagno F, Russo I (2003) Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells Arterioscler. Thromb Vasc Biol 23:2215-2221 (Pubitemid 37532323)
26. Das A, Xi L, Kukreja RC (2005) Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280:12944-12955
27. Patil CS, Singh VP, Singh S (2004) Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy. Pharmacology 72:190-195 (Pubitemid 39370248)
28. Zhang J, Kawashima S, Yokoyama M, Huang P, Hill CE (2007) Protective effect of endothelial nitric oxide synthase against induction of chemically-induced diabetes in mice. Nitric oxide 17:69-74 (Pubitemid 47259728)
29. Lincz LF (1998) Desiphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol 76:1-19 (Pubitemid 28194692)
30. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256
31. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A (2001) Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50:1683-1690 (Pubitemid 33641583)
32. Kim WH, Lee JW, Suh YH, Hong SH, Choi JS, Lim JH, Song JH, Gao B, Jung MH (2005) Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells. Diabetes 54:2602-2611 (Pubitemid 41233581)
33. Kianfar AH, Mohebbi S (2007) Synthesis and electrochemistry of vanadium (IV) Schiff base complexes. J Iran Chem Soc 4:215-220
34. Okhawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric reaction. Anal Biochem 95:351-358 (Pubitemid 9194347)
35. Kakkar R, Mantha VS, Radhi J, Prasad K, Kalra J (1998) Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94:623-632 (Pubitemid 28269062)
36. Kakkar R, Kalra J, Mantha SV, Prasad K (1995) Lipid peroxidation and antioxidant enzyme activity in streptozotocin-induced Fischer rats. Mol Cell Biochem 151:113-119
37. Balaraman R, Bafna PA, Kolhapure SA (2004) Antioxidant activity of DHC-1 - A herbal formulation. J Ethnopharmacol 94:135-141 (Pubitemid 38942845)
38. Jin R, Chow VT, Tan PH, Dheen ST, Duan W, Bay BH (2002) Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23:81-86 (Pubitemid 34213555)
39. Bandyopadhyay U, Das D, Banerjee RK (1999) Reactive oxygen species: Oxidative damage and pathogenesis. Curr Sci 77:658-666 (Pubitemid 129558409)
40. Rauscher FM, Ruth A, Watkins JB (2001) Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin induced diabetic rats. J Biochem Mol Toxicol 15:159-164 (Pubitemid 32514750)
41. Schechter Y, Perspectives in diabetes (1990) Insulin-mimetic effects of vanadate Possible implications for future treatment of diabetes. Diabetes 39:5
42. 2 as an intermediate. J Biol Chem 266:2112-2114 (Pubitemid 21909036)
43. Eslnar M, Guldbakke B, Tiedge M, Munday R, Lenzen S (2000) Relative importance of transport and alkylation for pancreatic betacells toxicity of streptozotocin. Diabetologia 43:1528-1533 (Pubitemid 32734859)
44. Cam MC, Li WM, McNeill JH (1997) Partial preservation of pancreatic b-cells by vanadium: evidence for long-term amelioration of diabetes. Metabolism 46:769-778 (Pubitemid 27300619)
45. Cam MC, Rodrigues B, McNeill JH (1999) Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes. Eur J Endocrinol 141:546-554
46. Shukla R, Anand K, Prabhu KM, Murthy PS (1995) Hypolipidemic effect of water extract of Ficus bengalensis in alloxan induced diabetes mellitus in rabbits. Indian J Clin Biochem 10:119-121 (Pubitemid 26038409)
47. Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP (1997) Antidiabetic and antihyperlipidemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol 29:162-167 (Pubitemid 27296934)
48. Shen GX (2007) Lipid Disorders in Diabetes Mellitus and Current Management. Curr Pharm Anal 3:17-24 (Pubitemid 46605114)
49. Baynes JW, Thorpe SR (1996) The role of oxidative stress in diabetic complications. Curr Opin Endocrinol 3:277-84 (Pubitemid 126441489)
50. Montilla PL, Vargas JF, Tunez IF, Munoz de Agueda MC, Valdelvira ME, Cabrera ES (1998) Oxidative stress in diabetic rats induced by streptozotocin: preventive effects of melatonin. J Pineal Res 25:94-100 (Pubitemid 28392105)
51. Matsubara T, Marcu SM, Misra PH, Dhalla NS (1995) Protective effect of vanadate on oxyradicleinduced changes in isolated perfused heart. Mol Cell Biochem 153:79-85 (Pubitemid 26003369)
52. Kakkar R, Mantha SV, Radhi J, Prasad K, Karla J (1998) Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94:623-632 (Pubitemid 28269062)
53. Tatsuki R, Satoh K, Yamamoto A, Hoshi K, Ichihara K (1997) Lipid peroxidation in the pancreas and other organs in streptozotocin diabetic rats. Jpn J Pharmacol 75:267-273 (Pubitemid 28000171)
54. Wohaieb AS, Godin DV (1987) Alterations in free radical tissue defence mechanism in streptozocin induced diabetes in rat. Diabetes 36:1014-1018 (Pubitemid 18088387)
55. Garg MC, Ojha S, Bansal DD (1996) Antioxidant status of streptozotocin diabetic rats. Indian J Exp Biol 34:264-266 (Pubitemid 26247847)
56. Robertson RP, Harmon J, Tran PO, Tanaka Y, Takahasi H (2003) Glucose toxicity in β cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581-587 (Pubitemid 36323562)
57. Yamashita T, Kawashima S, Ohashi Y (2000) Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36:97-102 (Pubitemid 30602159)